Serum leptin and lipid profile before and after Omega-3 supplementation fatty acid in neonates with IUGR

Serum leptin and lipid profile before and after Omega-3 supplementation fatty acid in neonates with IUGR: A randomized control trial - Nil

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/07/069980

Enrollment

Registered

2024-07-04

Start date

Unknown

Completion date

Unknown

Last updated

2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: P051- Newborn small for gestational age Health Condition 2: P059- Newborn affected by slow intrauterine growth, unspecified

Interventions

Intervention1: Omega -3fatty acid supplementation: 40 mg/kg/day in 10ml of expressed breast milk or formula milk daily in full term neonates with IUGR Control Intervention1: No intervention: No omega-

Eligibility

Inclusion criteria

Inclusion criteria: Full Term Neonate between thirty seven weeks to fourty one plus six weeks SGA Ponderal index less than two On full feeds

Exclusion criteria

Exclusion criteria: Preterm neonates Neonates who died before feeding is established neonates with congenital infection, with multiple congenital anomalies/malformation Neonates with Cholestasis

Design outcomes

Primary

Measure	Time frame
effects of Omega-3 fatty acid supplementation on serum leptin levels of IUGR neonatesTimepoint: At enrollment and at 4 week of supplementation	—

Secondary

Measure	Time frame
effects of omega 3 fatty acid supplementation on lipid profile and on anthropomertic measurementsTimepoint: lipid profile: at enrollment and after 4 weeks anthropometry: daily,weekly according to criteria	—

Countries

India

Contacts

Public ContactDr Jyoti

PGIMS,Rohtak, 124001

geetagathwala@gmail.com9896489650

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026